Abstract:Two delta8-THC derivatives, 4a and 4b, with functionalized side chains were synthesized. Treatment of (+)-trans-p-mentha-2,8-dien-1-ol with the resorcinal 2b followed by removal of the dithiol group with HgO--BF3-Et2O gave the aldehyde 3b. A Wittig reaction of dimethyl (2-oxoheptyl)phosphate with 3b furnished 4a, which was reduced to 4b. Compounds 4a and 4b showed potent cannabinoid-like activity in mice.
“…The synthesis was carried out analogous to the preparation of 4a using 13 (0.64 g, 2.64 mmol) and boron tribromide (0.56 mL, 5.81 mmol) in anhydrous CH 2 Cl 2 (66 mL). The reaction was completed in 48 h at −78 °C to 0 °C; yield: 87% (0.49 g); yellow gum; (lit …”
Section: Methodsmentioning
confidence: 99%
“…This was followed by demethylation under boron tribromide conditions affording resorcinol 4b in 84% yield. Similarly, 3,5-dimethoxybenzaldehyde 12 upon treatment with 1,2-ethanedithiol and boron trifluoride etherate gave thioketal 13 (87% yield) which was converted to the corresponding resorcinol 4c 28 in 87% yield, by demethylation using boron tribromide at 0 °C for 48 h.…”
Section: Chemistrymentioning
confidence: 99%
“…Following a well-established protocol, ,, Friedel−Crafts allylation (Scheme ) of resorcinol derivatives 4a , 4b , and 4c with (+)- cis/ trans-p -mentha-2,8-dien-1-ol catalyzed by p -toluenesulfonic acid afforded cannabidiols 3a , 3b , and 3c in 85%, 43%, and 30% yield, respectively. These intermediates were readily cyclized in the presence of boron trifluoride etherate to give the corresponding tetrahydrocannabinol analogues 2a , 2b , and 2c (Table ) in 79%, 69%, and 50% yield. …”
Earlier work from our laboratories has provided evidence for the existence of a subsite within the CB1 and CB2 cannabinoid receptor binding domain corresponding to substituents at the benzylic side chain position of classical cannabinoids. The existence and stereochemical features of this subsite have now been probed through the synthesis of a novel series of (-)-Delta(8)-tetrahydrocannabinol analogues bearing C1'-ring substituents. Of the compounds described here, those with C1'-dithiolane (1c), C1'-dioxolane (2d), and cyclopentyl (2a) substituents exhibited the highest affinities for CB1 and CB2. We used molecular modeling approaches to better define the stereochemical limits of the putative subsite. In vitro pharmacological testing found 1c to be a potent CB1 agonist.
“…The synthesis was carried out analogous to the preparation of 4a using 13 (0.64 g, 2.64 mmol) and boron tribromide (0.56 mL, 5.81 mmol) in anhydrous CH 2 Cl 2 (66 mL). The reaction was completed in 48 h at −78 °C to 0 °C; yield: 87% (0.49 g); yellow gum; (lit …”
Section: Methodsmentioning
confidence: 99%
“…This was followed by demethylation under boron tribromide conditions affording resorcinol 4b in 84% yield. Similarly, 3,5-dimethoxybenzaldehyde 12 upon treatment with 1,2-ethanedithiol and boron trifluoride etherate gave thioketal 13 (87% yield) which was converted to the corresponding resorcinol 4c 28 in 87% yield, by demethylation using boron tribromide at 0 °C for 48 h.…”
Section: Chemistrymentioning
confidence: 99%
“…Following a well-established protocol, ,, Friedel−Crafts allylation (Scheme ) of resorcinol derivatives 4a , 4b , and 4c with (+)- cis/ trans-p -mentha-2,8-dien-1-ol catalyzed by p -toluenesulfonic acid afforded cannabidiols 3a , 3b , and 3c in 85%, 43%, and 30% yield, respectively. These intermediates were readily cyclized in the presence of boron trifluoride etherate to give the corresponding tetrahydrocannabinol analogues 2a , 2b , and 2c (Table ) in 79%, 69%, and 50% yield. …”
Earlier work from our laboratories has provided evidence for the existence of a subsite within the CB1 and CB2 cannabinoid receptor binding domain corresponding to substituents at the benzylic side chain position of classical cannabinoids. The existence and stereochemical features of this subsite have now been probed through the synthesis of a novel series of (-)-Delta(8)-tetrahydrocannabinol analogues bearing C1'-ring substituents. Of the compounds described here, those with C1'-dithiolane (1c), C1'-dioxolane (2d), and cyclopentyl (2a) substituents exhibited the highest affinities for CB1 and CB2. We used molecular modeling approaches to better define the stereochemical limits of the putative subsite. In vitro pharmacological testing found 1c to be a potent CB1 agonist.
“…Δ 8 -THC also displays psychoactivity and is chemically more stable than Δ 9 -THC [32, 33]. Δ 8 -THC shows moderate partial agonistic effects on CB 1 and CB 2 receptors [34, 35].…”
Section: Pharmacology Of Selected Phytocannabinoidsmentioning
“…Caled for C 13 403 (mol wt 202): C, 77.20; H. 6.98. Found: C, 77.27; H, 6.9. 8-Methoxy-2a,3,4,5-tetrahydro-5-vinyl-5-acenaphthenol (15). A solution of 4.6 g (0.023 mol) of the ketone 14 in tetrahydrofuran (10 mL) and ether (15 mL) was added dropwise under nitrogen over 30 min to a stirred and cooled (NaCl, ice bath) solution of vinylmagnesium bromide prepared from 1.2 g (0.05 mol) of magnesium and 6.4 g (0.06 mol) of vinyl bromide in tetrahydrofuran-ether (10 + 10 mL).…”
THC bis(tert-butyldimethylsilyl) ether, 68582-90-1: 3-carbethox~;-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-l-ol t e r t -hutyldimethylsilyl ether. 68582-91-2; A 9 -T H C , 1972-08-3; Ag-'THC !er!hutyldimethylailyl ether, 61919-31-1; 1'-hydroxy-Sg-THC for!hutyldimethylsilyl ether (isomer A), 68582-92-3; m e t h y l 3,5-dihydroKybenzoate, 2150-44-9;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.